2020
DOI: 10.1016/j.intcar.2020.100001
|View full text |Cite
|
Sign up to set email alerts
|

COVID-19 disease: assessment of a critically ill patient

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
2
1
1
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 28 publications
0
3
0
Order By: Relevance
“…A variety of objective assessments are available for evaluating respiratory function. Primarily, pulmonary function tests (PFTs), encompassing spirometry, diffusion capacity, and lung volumes, are regularly utilized [14]. Among the critical impairment evaluations highlighted in the survey was the 6 minute walk test (6MWT).…”
Section: Assessment In Wardsmentioning
confidence: 99%
“…A variety of objective assessments are available for evaluating respiratory function. Primarily, pulmonary function tests (PFTs), encompassing spirometry, diffusion capacity, and lung volumes, are regularly utilized [14]. Among the critical impairment evaluations highlighted in the survey was the 6 minute walk test (6MWT).…”
Section: Assessment In Wardsmentioning
confidence: 99%
“…The essential physiological observations to decide whether a person is infected by COVID-19, include temperature, respiratory rate, oxygen saturation, pulse rate, blood pressure, and chest imaging as reported by Carter, Aedy, and Notter (2020) . Temperature measurement may be a part of the evaluation to decide whether a person has a high temperature potentially caused by an infection with COVID-19.…”
Section: Measurement and Testing Protocols Of Covid-19mentioning
confidence: 99%
“…Most moderately ill patients can recover after symptomatic and supportive treatment, while COVID-19 in severely ill/critically ill patients can be life-threatening due to a series of rapid pathophysiological changes such as body in ammatory response and "cytokine storm" [7][8][9]. Current diagnostic and therapeutic regimens emphasize early evaluation, and early treatment of severely ill/critically ill patients to help improve patient prognosis and reduce the risk of death [10][11][12][13]. We previously reported serum SARS-CoV-2 speci c Immunoglobulin A (IgA) is positively correlated with disease severity [14], and Krebs von den Lungen-6 (KL-6) is a good indicator for lung injury and in ammation in COVID-19 patients [15].…”
Section: Introductionmentioning
confidence: 99%